Higher visit-to-visit HbA1c variability in type 2 diabetes was linked to increased risk of all-cause mortality and nephropathy but not AMI, stroke, neuropathy, or LEA.
Does higher visit-to-visit HbA1c variability increase the risk of all-cause mortality and diabetes-related vascular complications in adult individuals with type 2 diabetes mellitus?
In adults with type 2 diabetes, higher visit-to-visit HbA1c variability is associated with an increased risk of mortality and nephropathy, suggesting that stable glycemic control is important for improving outcomes.
Absolute Event Rate: 0% vs 0%
Higher HbA1c variability was associated with significantly increased risk of mortality and nephropathy, but not significantly associated with the risk of AMI, stroke, neuropathy, or LEA.
Lim et al. (Thu,) reported a other. Higher visit-to-visit HbA1c variability in type 2 diabetes was linked to increased risk of all-cause mortality and nephropathy but not AMI, stroke, neuropathy, or LEA.